Exhausted B cells hamper immune response to HIV

Jul 14, 2008

Recent studies have shown that HIV causes a vigorous and prolonged immune response that eventually leads to the exhaustion of key immune system cells--CD4+ and CD8+ T-cells--that target HIV. These tired cells become less and less able to fight the virus, and the cells' fatigue contributes to the inability of an HIV-infected person's immune system to clear the virus from the body.

Now, researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have shown that a similar type of exhaustion strikes another important brigade of immune system soldiers: the B cells that make virus-fighting proteins called antibodies.

In most HIV-infected individuals not receiving antiretroviral therapy, the virus replicates continuously, causing systemic disturbances that include changes in certain subsets of B cells that circulate in the blood. One of these subsets, known as "tissue-like memory B cells," is abundant in HIV-infected individuals who do not control their viral burden. These particular cells show signs of premature exhaustion and a reduced ability to make the high-quality antibodies needed to fight HIV.

As with studies of exhausted CD4+ and CD8+ T cells, these new findings related to exhausted B cells help illuminate the complex immune system damage caused by HIV, and the challenges to rebuilding or bolstering an HIV-infected person's immune system.

NIAID's HIV vaccine research program aims to increase the understanding of B cells to help inform the development of an effective vaccine, and this study contributes to this effort. The authors note that the design of a therapeutic vaccine designed to slow HIV disease progression will need to overcome or circumvent the challenge posed by the inability of certain exhausted B cells to make high-quality antibodies.

Source: National Institute of Allergy and Infectious Diseases

Explore further: Small changes in eGFR with TDF preexposure prophylaxis

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Small changes in eGFR with TDF preexposure prophylaxis

Dec 23, 2014

(HealthDay)—For HIV-1-uninfected members of serodiscordant couples, tenofovir disoproxil fumarate (TDF) used as preexposure prophylaxis (PrEP) is associated with a small decrease in estimated glomerular ...

FDA to ease ban on blood donations by gay men

Dec 23, 2014

Federal officials have moved closer to overturning a decades-old ban on blood donations from gay and bisexual men, but activists say the proposed alternative would continue to stigmatize men who have sex ...

Consumer group sues Aetna, alleges discrimination

Dec 23, 2014

A consumer advocacy group has filed a class-action lawsuit against Aetna Inc. saying a new policy violates the privacy of people with HIV and AIDS by requiring them to get their medications from its mail-order pharmacy.

Cambodia orders probe into mass HIV infection

Dec 18, 2014

Cambodian Prime Minister Hun Sen on Thursday ordered a probe into an apparent mass HIV infection believed to have been spread by contaminated needles, as the number of suspected cases passed 100.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.